Who owns INTERCEPT PHARMACEUTICALS IN?
- CUSIP Number: 45845pac2
Tip: Access positions for across all investors
Analyze quarterly positions in Intercept Pharmaceuticals In with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Intercept Pharmaceuticals In stock
Who bought or sold INTERCEPT PHARMACEUTICALS IN this quarter?
There are no current stakeholders of Intercept Pharmaceuticals In.
This is normal when the security:
- Has been acquired or taken private
- Has merged with another entity
- Has changed its name and has a new CUSIP (and/or symbol)
- Has been delisted and the ticker has changed
Please use Search to find the security you were looking for.
Who sold out of Intercept Pharmaceuticals In?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Deerfield Management Company | Sep 2023 | 98M | $105M |
| Wolverine Asset Management | Sep 2023 | 7.8M | $8.4M |
| CSS | Sep 2023 | 4.5M | $4.8M |
| Citigroup | Sep 2023 | 262k | $281k |
| Jpmorgan Chase & Co | Sep 2023 | 175k | $188k |
| Jane Street | Sep 2023 | 60k | $64k |